If the target company
has little (or unpublicized) record of earnings, or is a technology (or
patent) that needs to gain industry acceptance, be prosecuted, nurtured
or further developed, (unless it's really high profile) we likely won't
even maintain our current stock price.

What about probable revalidation of the MMP?

What about increasing licensing and increasing fees then?

What about the current assets of our company? Am I wrong to judge by this that we are undervalued?

What about possible additional payments of companies who did agree in business resolution perhaps after revalidation?

I do not consider it to be fair to point out just one special aspect -in this case M&A- and from here derive a likely lower stock price.

I learned that one only gets a correct image of anything if one looks at the whole picture.

To pick a certain aspect, just leave out all the other possibilities, is what is commonly referred to as manipulating in my opinion.

All the best to everyone,

Jerry